We are live on
!
Find out more
FS
Financial Symmetry Portfolio holdings
AUM
$300M
1-Year Est. Return
23.79%
This Fund
S&P 500
This Quarter
Est. Return
+6.24%
1 Year Est. Return
+23.79%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
+$12.7M
(+12%)
Cap. Flow
+$6.26M
Cap. Flow
% of AUM
5.48%
Top 10 Holdings %
Top 10 Hldgs %
85.4%
Holding
37
New
5
Increased
16
Reduced
9
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional World ex US Core Equity 2 ETF
DFAX
|
+$2.67M |
| 2 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$765K |
| 3 |
Dimensional Core Fixed Income ETF
DFCF
|
+$648K |
| 4 |
NVIDIA
NVDA
|
+$338K |
| 5 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$334K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total World Stock ETF
VT
|
+$255K |
| 2 |
Johnson & Johnson
JNJ
|
+$207K |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
+$42.6K |
| 4 |
Cisco
CSCO
|
+$24.6K |
| 5 |
Avantis International Equity ETF
AVDE
|
+$20.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.42% |
| 2 | Consumer Discretionary | 1.02% |
| 3 | Communication Services | 0.6% |
| 4 | Financials | 0.38% |
| 5 | Healthcare | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
IBM
IBM
$224B
| $344K | 0.3% |
1,804
-18
| -1% | -$3.28K |
|
27
Dimensional International Value ETF
DFIV
$21.6B
| $320K | 0.28% |
8,701
| – | – |
|
28
Vertex Pharmaceuticals
VRTX
$126B
| $316K | 0.28% |
755
| – | – |
|
29
Dimensional US Small Cap ETF
DFAS
$15.7B
| $304K | 0.27% |
4,874
+242
| +5% | +$14.3K |
|
|
DFSD
30
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.15B
| $302K | 0.26% |
+6,423
| New | +$302K |
|
31
Avantis US Small Cap Value ETF
AVUV
$30.9B
| $271K | 0.24% |
2,890
| – | – |
|
32
McDonald's
MCD
$195B
| $231K | 0.2% |
820
-70
| -8% | -$20.4K |
|
33
Mastercard
MA
$493B
| $226K | 0.2% |
470
-6
| -1% | -$2.74K |
|
34
TXO Partners LP
TXO
$760M
| $226K | 0.2% |
+12,568
| New | +$230K |
|
35
Visa
V
$677B
| $203K | 0.18% |
+727
| New | +$201K |
|
|
PVCT
36
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
| $1.86K | ﹤0.01% |
10,191
| – | – |
|
|
37
Johnson & Johnson
JNJ
$625B
| – | – |
-1,319
| Closed | -$207K |
|
Similar funds
RCA
UCB
KEM
RP
I
SC
FPCG
GB
Financial Symmetry's Q1 2024 Portfolio in Review
As of Q1 2024, Financial Symmetry held 37 positions worth $114M, up 12% from $102M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Financial Symmetry deployed $6.26M of net new capital in Q1 2024, opening 5 new positions and adding to 16 existing holdings. Its largest new stake was Dimensional Core Fixed Income ETF: 15,427 shares worth $647K.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.5% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Vanguard Total World Stock ETF, an estimated $255K trimmed.
- Financial Symmetry's largest Q1 2024 buy was Dimensional Core Fixed Income ETF: 15,427 shares worth $647K.
- Financial Symmetry added most to Dimensional World ex US Core Equity 2 ETF in Q1 2024, an estimated $2.67M increase.
- Financial Symmetry's biggest Q1 2024 reduction was Vanguard Total World Stock ETF, cutting an estimated $255K.
- Financial Symmetry fully exited Johnson & Johnson in Q1 2024, selling an estimated $207K.
- Financial Symmetry's ten largest holdings make up 85% of its $114M portfolio in Q1 2024.
- Financial Symmetry opened 5 new positions and closed 1 in Q1 2024.
- Financial Symmetry's portfolio value rose 12% quarter-over-quarter to $114M.
Based on Financial Symmetry's 13F filing for Q1 2024, filed 30 Apr 2024.